Initial Invasive or Conservative Strategy for Stable Coronary Disease
Maron, David J, Hochman, Judith S, Reynolds, Harmony R, Bangalore, Sripal, O’Brien, Sean M, Boden, William E, Chaitman, Bernard R, Senior, Roxy, López-Sendón, Jose, Alexander, Karen P, Lopes, Renato D, Shaw, Leslee J, Berger, Jeffrey S, Newman, Jonathan D, Sidhu, Mandeep S, Goodman, Shaun G, Ruzyllo, Witold, Gosselin, Gilbert, Maggioni, Aldo P, White, Harvey D, Bhargava, Balram, Min, James K, Mancini, G.B. John, Berman, Daniel S, Picard, Michael H, Kwong, Raymond Y, Ali, Ziad A, Mark, Daniel B, Spertus, John A, Krishnan, Mangalath N, Elghamaz, Ahmed, Moorthy, Nagaraja, Hueb, Whady A, Demkow, Marcin, Mavromatis, Kreton, Bockeria, Olga, Peteiro, Jesus, Miller, Todd D, Szwed, Hanna, Doerr, Rolf, Keltai, Matyas, Selvanayagam, Joseph B, Steg, P. Gabriel, Held, Claes, Kohsaka, Shun, Mavromichalis, Stavroula, Kirby, Ruth, Jeffries, Neal O, Harrell, Frank E, Rockhold, Frank W, Broderick, Samuel, Ferguson, T. Bruce, Williams, David O, Harrington, Robert A, Stone, Gregg W, Rosenberg, Yves
Published in The New England journal of medicine (09.04.2020)
Published in The New England journal of medicine (09.04.2020)
Get full text
Journal Article
Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease
WHITE, Harvey D, HELD, Claes, ARMSTRONG, Paul W, AVEZUM, Alvaro, AYLWARD, Philip E, BRYCE, Alfonso, HONG CHEN, CHEN, Ming-Fong, CORBALAN, Ramon, DALBY, Anthony J, DANCHIN, Nicolas, DE WINTER, Robbert J, STEWART, Ralph, DENCHEV, Stefan, DIAZ, Rafael, ELISAF, Moses, FLATHER, Marcus D, GOUDEV, Assen R, GRANGER, Christopher B, GRINFELD, Liliana, HOCHMAN, Judith S, HUSTED, Steen, KIM, Hyo-Soo, TARKA, Elizabeth, WOLFGANG KOENIG, LINHART, Ales, LONN, Eva, LOPEZ-SENDON, José, MANOLIS, Athanasios J, MOHLER, Emile R, NICOLAU, José C, PAIS, Prem, PARKHOMENKO, Alexander, PEDERSEN, Terje R, BROWN, Rebekkah, PELLA, Daniel, RAMOS-CORRALES, Marco A, RUDA, Mikhail, SEREG, Mátyás, SIDDIQUE, Saulat, SINNAEVE, Peter, SMITH, Peter, SRITARA, Piyamitr, SWART, Henk P, SY, Rody G, DAVIES, Richard Y, TERAMOTO, Tamio, TSE, Hung-Fat, WATSON, David, WEAVER, W. Douglas, WEISS, Robert, VIIGIMAA, Margus, VINEREANU, Dragos, JUNREN ZHU, CANNON, Christopher P, BUDAJ, Andrzej, HARRINGTON, Robert A, STEG, P. Gabriel, ARDISSINO, Diego
Published in The New England journal of medicine (01.05.2014)
Published in The New England journal of medicine (01.05.2014)
Get full text
Journal Article
Low-density lipoprotein cholesterol <50 mg/dL is an appropriate target after acute coronary syndrome: propensity score-matched analysis of the ODYSSEY OUTCOMES trial
Schwartz, G.G, Szarek, M, Bhatt, D.L, Bittner, V.A, Diaz, R, Goodman, S.G, Harrington, R.A, Jukema, J.W, Kim, Y.U, Li, Q.H, Manvelian, G, White, H.D, Zeiher, A.M, Steg, P.G
Published in European heart journal (01.11.2020)
Published in European heart journal (01.11.2020)
Get full text
Journal Article
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial
White, Harvey D, Steg, Ph Gabriel, Szarek, Michael, Bhatt, Deepak L, Bittner, Vera A, Diaz, Rafael, Edelberg, Jay M, Erglis, Andrejs, Goodman, Shaun G, Hanotin, Corinne, Harrington, Robert A, Jukema, J Wouter, Lopes, Renato D, Mahaffey, Kenneth W, Moryusef, Angele, Pordy, Robert, Roe, Matthew T, Sritara, Piyamitr, Tricoci, Pierluigi, Zeiher, Andreas M, Schwartz, Gregory G
Published in European heart journal (01.09.2019)
Published in European heart journal (01.09.2019)
Get full text
Journal Article
Effect of alirocumab on incidence of atrial fibrillation after acute coronary syndromes: insights from ODYSSEY OUTCOMES
Lopes, R, Steg, P.G, Bhatt, D.L, Bittner, V.A, Dauchy, A, Diaz, R, Goodman, S.G, Harrington, R.A, Jukema, J.W, Pordy, R, Sourdille, T, Szarek, M, White, H.D, Zeiher, A.M, Schwartz, G.G
Published in European heart journal (01.11.2020)
Published in European heart journal (01.11.2020)
Get full text
Journal Article
Cost-effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease with a history of PCI: an economic evaluation of THEMIS-PCI using a Swedish healthcare perpective
Steg, P, Bhatt, D.L, James, S.K, Darlington, O, Hoskin, L, Simon, T, Fox, K, Leiter, L.A, Mehta, S, Harrington, R.A, Himmelmann, A, Ridderstrale, W, Andersson, M, Mellstrom, C, Mcewan, P
Published in European heart journal (01.11.2020)
Published in European heart journal (01.11.2020)
Get full text
Journal Article
P5599Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis
Chi, G., Nafee, T., Korjian, S., Daaboul, Y., Harrington, R.A., Goldhaber, S.Z., Hull, R.D., Gold, A., Cohen, A.T., Gibson, C.M.
Published in European heart journal (01.08.2017)
Published in European heart journal (01.08.2017)
Get full text
Journal Article
P4316N-terminal pro-B-type natriuretic peptide (NT-proBNP) is associated with stroke among hospitalized medical patients: an APEX trial substudy
Chi, G., Nafee, T., Korjian, S., Daaboul, Y., Harrington, R.A., Goldhaber, S.Z., Hull, R.D., Gold, A., Cohen, A.T., Gibson, C.M.
Published in European heart journal (01.08.2017)
Published in European heart journal (01.08.2017)
Get full text
Journal Article
P1732Extended duration betrixaban in acutely ill medical patients is associated with reduction in fatal or irreversible ischemic or bleeding events compared with standard dose enoxaparin: an APEX substudy
Gibson, C.M., Arbetter, D.F., Jain, P., Halaby, R., Chi, G., Nafee, T., Korjian, S., Daaboul, Y., Goldhaber, S.Z., Hull, R.D., Gold, A., Hernandez, A.F., Cohen, A.T., Harrington, R.A.
Published in European heart journal (01.08.2017)
Published in European heart journal (01.08.2017)
Get full text
Journal Article
P1551D-dimer concentration is associated with increased risk for VTE and greater absolute benefit of extended prophylaxis with betrixaban in acutely Ill medical patients: insights from the APEX trial
Gibson, C.M., Arbetter, D.F., Jain, P., Halaby, R., Chi, G., Nafee, T., Korjian, S., Daaboul, Y., Harrington, R.A., Goldhaber, S.Z., Hull, R.D., Gold, A., Cohen, A.T.
Published in European heart journal (01.08.2017)
Published in European heart journal (01.08.2017)
Get full text
Journal Article
P5600History of venous thromboembolism is associated with higher risk for recurrent venous thromboembolism: insights from the APEX trial
Yee, M.K., Chi, G., Nafee, T., Korjian, S., Daaboul, Y., Harrington, R.A., Goldhaber, S.Z., Hull, R.D., Gold, A., Cohen, A.T., Gibson, C.M.
Published in European heart journal (01.08.2017)
Published in European heart journal (01.08.2017)
Get full text
Journal Article
Effect of extended‐duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis
Chi, G., Goldhaber, S. Z., Kittelson, J. M., Turpie, A. G. G., Hernandez, A. F., Hull, R. D., Gold, A., Curnutte, J. T., Cohen, A. T., Harrington, R. A., Gibson, C. M.
Published in Journal of thrombosis and haemostasis (01.10.2017)
Published in Journal of thrombosis and haemostasis (01.10.2017)
Get full text
Journal Article
3111Genetic variability in PAR4 platelet response in relation to bleeding and ischemic outcomes: a genetic substudy of the TRACER trial
Tricoci, P., Neely, M., Whitley, M., Edelstein, L., Simon, L.M., Shaw, C., Moliterno, D.J., Armstrong, P.W., White, H.D., Van de Werf, F., Jennings, L.K., Wallentin, L., Harrington, R.A., Mahaffey, K.W., Bray, P.F.
Published in European heart journal (01.08.2017)
Published in European heart journal (01.08.2017)
Get full text
Journal Article
Venous thromboembolism prophylaxis: do trial results enable clinicians and patients to evaluate whether the benefits justify the risk? Proceedings of an Ad Hoc Working Group Meeting
Berger, J., Eikelboom, J. W., Quinlan, D. J., Guyatt, G., Büller, H. R., Sobieraj‐Teague, M., Harrington, R. A., Hirsh, J.
Published in Journal of thrombosis and haemostasis (01.04.2013)
Published in Journal of thrombosis and haemostasis (01.04.2013)
Get full text
Journal Article
First experience with direct, selective factor Xa inhibition in patients with non‐ST‐elevation acute coronary syndromes: results of the XaNADU‐ACS Trial
ALEXANDER, J. H., YANG, H., BECKER, R. C., KODAMA, K., GOODMAN, S., DYKE, C. K., KLEIMAN, N. S., HOCHMAN, J. S., BERGER, P. B., COHEN, E. A., LINCOFF, A. M., BURTON, J. R., BOVILL, E. G., KAWAI, C., ARMSTRONG, P. W., HARRINGTON, R. A.
Published in Journal of thrombosis and haemostasis (01.03.2005)
Published in Journal of thrombosis and haemostasis (01.03.2005)
Get full text
Journal Article
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes
Roe, M.T., Mahaffey, K.W., Kilaru, R., Alexander, J.H., Akkerhuis, K.M., Simoons, M.L., Harrington, R.A., Tardiff, B.E., Granger, C.B., Ohman, E.M., Moliterno, D.J., Lincoff, A.M., Armstrong, P.W., Van de Werf, F., Califf, R.M., Topol, E.J.
Published in European heart journal (01.02.2004)
Published in European heart journal (01.02.2004)
Get full text
Journal Article